| Literature DB >> 35461249 |
Hélène Warnier1, Christophe Barrea2, Sarah Bethlen3, Isabelle Schrouff4, Julie Harvengt5.
Abstract
BACKGROUND: Stuve-Wiedemann syndrome (SWS) is a rare and severe genetic disease characterized by skeletal anomalies and dysautonomic disturbances requiring appropriate care. Peer support is mandatory to fill the lack of clinical recommendations in such rare diseases. We report a new case and provide the first systematic review of all previous published cases.Entities:
Keywords: Dysautonomia; Multidisciplinary care; Skeletal dysplasia; Stuve-Wiedemann syndrome
Mesh:
Year: 2022 PMID: 35461249 PMCID: PMC9034487 DOI: 10.1186/s13023-022-02323-8
Source DB: PubMed Journal: Orphanet J Rare Dis ISSN: 1750-1172 Impact factor: 4.303
Fig. 1Our case report pictures. A Our patient at 8 months of age: no significative dysmorphism, bilateral short and bowed legs. B A clinical thoracolumbar scoliosis was observed since the age of 6 weeks, the picture shows the evolution at the age of 14 months. C Inferior limb radiology: bowed femur and tibia, diaphyseal cortical thickening at the concavity and wide metaphysis
Fig. 2Preferred reporting items for systematic reviews and meta-analysis individual patient data (IPD) flow diagram (based on Stewart et al. [11])
Details of the demographic features for the cohort (n = 69)
| Sex ratio (n = 61) | M/F = 0.97 (NR: 8) | |
| Reported consanguinity (n = 62) | 40/62 (65%) (NR: 7) | |
| Affected relatives (n = 69) | 38/69 (55%) | |
| Median age at report (25th–75th percentile) | 32 months (11.5–72 months) | |
| Geographic origin (n = 69) | Europe 35/69 (51%) Middle East 22/69 (32%) Africa 8/69 (12%) South or central America 4/69 (6%) | |
| Mortality rate (n = 69) | Total cohort: 32/69 (46%) | < 2 years: 29/69 (42%) ≥ 2 years: 3/31 (10%) |
| Age at death (n = 32) | Median (25th–75th percentile): 7.5 months (3–18 months) | Neonatal period (< 1 month): 14/32 (44%) Infancy (1 month–2 years):15/32 (47%) Childhood (> 2 years): 3/32 (9%) |
| Cause of death (n = 32) | Respiratory failure 14/32 (44%) Hyperthermic episode 9/32 (28%) Sudden death 2/32 (6%) Necrotizing enterocolitis 2/32 (6%) Post-operative 2/32 (6%) Not reported 3/32 (9%) | Respiratory failure or PAH: 10/14 Hyperthermic episode or sudden death: 1/14 Other cause: 3/14 Respiratory failure or PAH: 2/15 Hyperthermic episode or sudden death: 10/15 Other cause: 3/15 Respiratory failure or PAH: 2/3 Hyperthermic episode or sudden death: 0/15 Other cause: 1/3 |
Antenatal and neonatal features reported in the cohort (n = 69)
| Present | Absent | Not reported | |
|---|---|---|---|
| In utero detection of short/bowed limbs | 22 (32%) | 32 (46%) | 15 |
| Intra-uterine growth restriction | 12 (17%) | 35 (51%) | 22 |
| Oligoamnios | 11 (16%) | 9 (13%) | 49 |
| Reduced fetal movements | 6 (9%) | 3 (4%) | 60 |
| Poor neonatal adaptation | 10 (15%) | 8 (12%) | 51 |
Details of the dysmorphic features reported in the cohort (n = 69)
| Retrognathia or micrognathia | 28/69 (41%) |
| Short wide nose | 23/69 (33%) |
| Low set ears | 21/69 (30%) |
| Lips abnomalities | 21/69 (30%) |
| Pursed mouth | 19/69 (28%) |
| Midface hypoplasia | 19/69 (28%) |
| Square jaw or square face | 15/69 (22%) |
Osteo-articular characteristics reported in the total cohort and in the two sub-groups (< and ≥ 2 years)
| Total cohort (n = 69) | ≥ 2 years (n = 31) | < 2 years (n = 38) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Yes | No | NR | Yes | No | NR | Yes | No | NR/NA | |
| Short and bowed limbs | 69 (100%) | – | – | 31 (100%) | – | – | 38 (100%) | – | – |
| Camptodactyly | 55 (80%) | 2 | 12 | 25 (81%) | 2 | 4 | 30 (79%) | – | 8 |
| Joint mobility restriction | 45 (65%) | 5 | 19 | 25 (81%) | 2 | 4 | 20 (53%) | 3 | 15 |
| Fractures | 21 (30%) | 18 | 30 | 19 (61%) | 12 | – | 2 (5%) | 6 | 30 |
| Osteoporosis/osteopenia | 19 (28%) | 2 | 48 | 15 (48%) | – | 16 | 4 (11%) | 2 | 32 |
| Spinal deformation | 30 (44%) | 21 | 18 | 24 (77%) | 5 | 2 | 6 (16%) | 16 | 16 |
| Feet malposition | 35 (51%) | 9 | 25 | 14 (45%) | 8 | 9 | 21 (55%) | 1 | 16 |
| Growth retardation | 39 (57%) | 5 | 25 | 27 (87%) | 1 | 3 | 12 (32%) | 4 | 22 |
Non-orthopedic manifestations described in the total cohort and in the two subgroups (< and ≥ 2 years)
| Total cohort (n = 69) | ≥ 2 years (n = 31) | < 2 years (n = 38) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Yes | No | NR | Yes | No | NR | Yes | No | NR/NA | |
| Hyperthermia | 58 (84%) | 5 | 6 | 31 (100%) | – | – | 27 (71%) | 5 | 6 |
| Hypothermia | 7 (11%) | 6 | 56 | 6 (19%) | 6 | 19 | 1 (3%) | – | 37 |
| Poor temperature regulation | 32 (46%) | – | 37 | 28 (90%) | – | 3 | 4 (11%) | – | 34 |
| Excessive/paradoxical sweating | 33 (48%) | 4 | 32 | 26 (83%) | 2 | 3 | 7 (18%) | 2 | 29 |
| Respiratory distress | 56 (81%) | 4 | 9 | 24 (77%) | 4 | 3 | 32 (84%) | – | 6 |
| PAH | 8 (12%) | – | 61 | 1 (3%) | – | 30 | 7 (18%) | – | 31 |
| Hypolacrimation | 13 (19%) | 6 | 50 | 8 (26%) | 2 | 21 | 5 (13%) | 4 | 29 |
| Corneal opacities | 18 (26%) | 9 | 42 | 14 (45%) | 4 | 12 | 3 (8%) | 5 | 30 |
| Absent corneal reflex | 19 (28%) | 8 | 42 | 15 (48%) | 6 | 10 | 4 (10%) | 2 | 32 |
| Smooth tongue | 21 (30%) | 1 | 47 | 19 (61%) | – | 12 | 2 (5%) | 1 | 35 |
| Tongue injury | 17 (25%) | 3 | 49 | 15 (48%) | 2 | 14 | 2 (5%) | 1 | 35 |
| Poor dentition | 22 (32%) | 3 | 44 | 22 (71%) | 3 | 6 | – | – | 38 |
| Swallowing trouble | 58 (84%) | 3 | 8 | 30 (97%) | – | 1 | 28 (74%) | 3 | 7 |
| Abnormal perception of pain | 30 (44%) | 2 | 37 | 24 (77%) | 2 | 5 | 6 (16%) | – | 32 |
| Trismus or myotonia | 19 (28%) | 17 | 33 | 11 (36%) | 8 | 12 | 8 (21%) | 9 | 21 |
| Hypotonia | 41(59%) | 1 | 27 | 14 (45%) | – | 17 | 27 (71%) | 1 | 10 |
| Hyporeflexia | 10 (15%) | 11 | 48 | 8 (26%) | 8 | 15 | 2 (5%) | 3 | 33 |
| Delayed motor skills | 28 (41%) | – | 41 | 26 (84%) | – | 5 | 2 (5%) | – | 36 |
| Normal cognitive level | 25 (36%) | 1 | 43 | 24 (77%) | 1 | 6 | 1 (3%) | – | 37 |
| Seizure | 11 (16%) | 8 | 50 | 5 (16%) | 3 | 23 | 6 (16%) | 5 | 27 |
Fig. 3Summary of the disease timeline: clinical evolution for SWS patients before 2 years (Neonate and Infant) and after 2 years of age (represented by the child column). PAH = Pulmonary Arterial Hypertension
Suggested framework for further reports
Short and bowed long bones Oligoamnios Intra-uterine growth restriction |
Explicitly report as present or absent Age of occurrence Age of resolution if applicable (Proposed management) |